![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: HERC2 |
Gene summary for HERC2 |
![]() |
Gene information | Species | Human | Gene symbol | HERC2 | Gene ID | 8924 |
Gene name | HECT and RLD domain containing E3 ubiquitin protein ligase 2 | |
Gene Alias | D15F37S1 | |
Cytomap | 15q13.1 | |
Gene Type | protein-coding | GO ID | GO:0006139 | UniProtAcc | A8KAQ8 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
8924 | HERC2 | CA_HPV_1 | Human | Cervix | CC | 7.51e-03 | -1.56e-02 | 0.0264 |
8924 | HERC2 | CCI_2 | Human | Cervix | CC | 2.15e-06 | 1.05e+00 | 0.5249 |
8924 | HERC2 | CCI_3 | Human | Cervix | CC | 4.88e-04 | 6.48e-01 | 0.516 |
8924 | HERC2 | HTA11_3410_2000001011 | Human | Colorectum | AD | 1.60e-22 | -6.75e-01 | 0.0155 |
8924 | HERC2 | HTA11_2487_2000001011 | Human | Colorectum | SER | 2.34e-07 | -5.43e-01 | -0.1808 |
8924 | HERC2 | HTA11_3361_2000001011 | Human | Colorectum | AD | 2.54e-06 | -5.44e-01 | -0.1207 |
8924 | HERC2 | HTA11_5212_2000001011 | Human | Colorectum | AD | 3.33e-02 | -5.94e-01 | -0.2061 |
8924 | HERC2 | HTA11_5216_2000001011 | Human | Colorectum | SER | 4.57e-02 | -6.25e-01 | -0.1462 |
8924 | HERC2 | HTA11_7862_2000001011 | Human | Colorectum | AD | 2.67e-04 | -6.39e-01 | -0.0179 |
8924 | HERC2 | HTA11_4255_2000001011 | Human | Colorectum | SER | 4.57e-02 | -5.76e-01 | 0.0446 |
8924 | HERC2 | HTA11_9408_2000001011 | Human | Colorectum | AD | 2.17e-02 | -4.50e-01 | 0.0451 |
8924 | HERC2 | HTA11_8622_2000001021 | Human | Colorectum | SER | 8.01e-03 | -4.49e-01 | 0.0528 |
8924 | HERC2 | HTA11_6818_2000001021 | Human | Colorectum | AD | 2.78e-04 | -3.81e-01 | 0.0588 |
8924 | HERC2 | HTA11_99999970781_79442 | Human | Colorectum | MSS | 7.09e-09 | -4.53e-01 | 0.294 |
8924 | HERC2 | HTA11_99999965104_69814 | Human | Colorectum | MSS | 2.70e-21 | 1.25e+00 | 0.281 |
8924 | HERC2 | A001-C-207 | Human | Colorectum | FAP | 2.32e-03 | -9.84e-02 | 0.1278 |
8924 | HERC2 | A015-C-203 | Human | Colorectum | FAP | 5.73e-37 | -2.32e-01 | -0.1294 |
8924 | HERC2 | A015-C-204 | Human | Colorectum | FAP | 1.96e-08 | -8.87e-02 | -0.0228 |
8924 | HERC2 | A014-C-040 | Human | Colorectum | FAP | 3.10e-08 | 4.27e-03 | -0.1184 |
8924 | HERC2 | A002-C-201 | Human | Colorectum | FAP | 6.39e-19 | -2.45e-01 | 0.0324 |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0412014 | Cervix | CC | Ubiquitin mediated proteolysis | 49/1267 | 142/8465 | 4.26e-09 | 7.68e-08 | 4.54e-08 | 49 |
hsa0412015 | Cervix | CC | Ubiquitin mediated proteolysis | 49/1267 | 142/8465 | 4.26e-09 | 7.68e-08 | 4.54e-08 | 49 |
hsa04120 | Colorectum | AD | Ubiquitin mediated proteolysis | 58/2092 | 142/8465 | 1.46e-05 | 1.53e-04 | 9.76e-05 | 58 |
hsa041201 | Colorectum | AD | Ubiquitin mediated proteolysis | 58/2092 | 142/8465 | 1.46e-05 | 1.53e-04 | 9.76e-05 | 58 |
hsa041202 | Colorectum | SER | Ubiquitin mediated proteolysis | 39/1580 | 142/8465 | 6.18e-03 | 3.66e-02 | 2.66e-02 | 39 |
hsa041203 | Colorectum | SER | Ubiquitin mediated proteolysis | 39/1580 | 142/8465 | 6.18e-03 | 3.66e-02 | 2.66e-02 | 39 |
hsa041204 | Colorectum | MSS | Ubiquitin mediated proteolysis | 55/1875 | 142/8465 | 5.02e-06 | 6.00e-05 | 3.68e-05 | 55 |
hsa041205 | Colorectum | MSS | Ubiquitin mediated proteolysis | 55/1875 | 142/8465 | 5.02e-06 | 6.00e-05 | 3.68e-05 | 55 |
hsa041206 | Colorectum | FAP | Ubiquitin mediated proteolysis | 51/1404 | 142/8465 | 1.55e-08 | 5.84e-07 | 3.55e-07 | 51 |
hsa041207 | Colorectum | FAP | Ubiquitin mediated proteolysis | 51/1404 | 142/8465 | 1.55e-08 | 5.84e-07 | 3.55e-07 | 51 |
hsa041208 | Colorectum | CRC | Ubiquitin mediated proteolysis | 42/1091 | 142/8465 | 9.98e-08 | 6.67e-06 | 4.52e-06 | 42 |
hsa041209 | Colorectum | CRC | Ubiquitin mediated proteolysis | 42/1091 | 142/8465 | 9.98e-08 | 6.67e-06 | 4.52e-06 | 42 |
hsa0412026 | Esophagus | HGIN | Ubiquitin mediated proteolysis | 49/1383 | 142/8465 | 7.78e-08 | 1.33e-06 | 1.06e-06 | 49 |
hsa04120111 | Esophagus | HGIN | Ubiquitin mediated proteolysis | 49/1383 | 142/8465 | 7.78e-08 | 1.33e-06 | 1.06e-06 | 49 |
hsa0412027 | Esophagus | ESCC | Ubiquitin mediated proteolysis | 122/4205 | 142/8465 | 6.53e-20 | 7.29e-18 | 3.74e-18 | 122 |
hsa0412036 | Esophagus | ESCC | Ubiquitin mediated proteolysis | 122/4205 | 142/8465 | 6.53e-20 | 7.29e-18 | 3.74e-18 | 122 |
hsa0412010 | Liver | NAFLD | Ubiquitin mediated proteolysis | 44/1043 | 142/8465 | 2.59e-09 | 1.70e-07 | 1.37e-07 | 44 |
hsa0412011 | Liver | NAFLD | Ubiquitin mediated proteolysis | 44/1043 | 142/8465 | 2.59e-09 | 1.70e-07 | 1.37e-07 | 44 |
hsa0412021 | Liver | Cirrhotic | Ubiquitin mediated proteolysis | 72/2530 | 142/8465 | 1.32e-07 | 1.97e-06 | 1.21e-06 | 72 |
hsa0412031 | Liver | Cirrhotic | Ubiquitin mediated proteolysis | 72/2530 | 142/8465 | 1.32e-07 | 1.97e-06 | 1.21e-06 | 72 |
Page: 1 2 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
HERC2 | SNV | Missense_Mutation | c.3470N>G | p.Ala1157Gly | p.A1157G | O95714 | protein_coding | tolerated(0.23) | benign(0.098) | TCGA-49-4487-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
HERC2 | SNV | Missense_Mutation | c.6553G>T | p.Gly2185Trp | p.G2185W | O95714 | protein_coding | tolerated(0.19) | benign(0.319) | TCGA-49-4494-01 | Lung | lung adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | PD | |
HERC2 | SNV | Missense_Mutation | c.1562G>T | p.Cys521Phe | p.C521F | O95714 | protein_coding | tolerated(0.08) | probably_damaging(0.993) | TCGA-49-AARE-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | PD | |
HERC2 | SNV | Missense_Mutation | c.13004A>T | p.Tyr4335Phe | p.Y4335F | O95714 | protein_coding | tolerated(0.08) | possibly_damaging(0.66) | TCGA-49-AARQ-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
HERC2 | SNV | Missense_Mutation | c.4862N>T | p.Trp1621Leu | p.W1621L | O95714 | protein_coding | tolerated(0.39) | possibly_damaging(0.901) | TCGA-50-5941-01 | Lung | lung adenocarcinoma | Female | <65 | III/IV | Unspecific | Cisplatin | Complete Response | |
HERC2 | SNV | Missense_Mutation | c.11512N>T | p.Gly3838Cys | p.G3838C | O95714 | protein_coding | deleterious(0) | possibly_damaging(0.896) | TCGA-50-5946-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | PD | |
HERC2 | SNV | Missense_Mutation | novel | c.8479N>T | p.Asp2827Tyr | p.D2827Y | O95714 | protein_coding | deleterious(0.01) | probably_damaging(0.999) | TCGA-53-A4EZ-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Chemotherapy | cisplatin | CR |
HERC2 | SNV | Missense_Mutation | c.8917N>T | p.Gly2973Cys | p.G2973C | O95714 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-55-6969-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
HERC2 | SNV | Missense_Mutation | c.9305N>T | p.Arg3102Leu | p.R3102L | O95714 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-55-6981-01 | Lung | lung adenocarcinoma | Female | <65 | III/IV | Chemotherapy | chemo | CR | |
HERC2 | SNV | Missense_Mutation | novel | c.9797N>T | p.Ala3266Val | p.A3266V | O95714 | protein_coding | deleterious(0) | benign(0.341) | TCGA-55-7281-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Chemotherapy | carboplatin | PD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
8924 | HERC2 | DNA REPAIR, ENZYME | NERATINIB | NERATINIB | 23220880 |
Page: 1 |